Updated: Jun 08, 2022 13:53 IST
Research: Is the cost of treating a hereditary neuromuscular disease affected by the timing of treatment?
New Jersey [US], June 8 (ANI): Early detection and treatment of children with spinal muscular atrophy (SMA), a genetic ailment characterised by muscle weakness and wasting, can minimise the total financial expenditures associated with the condition, according to new research.
Read more
हिंदी खबर